Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns)Vanessa L. Beesley, Michael Friedländer, Christina M. Nagle et al.|Gynecologic Oncology|2021Cited by 36
Insomnia and its association with quality of life in women with ovarian cancerTanya L. Ross, Vanessa L. Beesley, Anna DeFazio et al.|Gynecologic Oncology|2020Cited by 33